To assess the effectiveness of TCLN technology in detecting RNA biomarkers in PCa-derived EVs, EVs were isolated from the PC3 metastatic prostate cancer cell line and analysed for the co-localisation of miR−141 with CD63-labelled EVs. This evidence concerns the gene CD63 and prostate carcinoma.